Trade Summary

3 months ago, Hawryluk P. Kent, serving as Pres, CEO at Mbx Biosciences, Inc. (MBX), purchased 18,500 shares at $28.41 per share, for a total transaction value of $525,663.00. Following this transaction, Hawryluk P. Kent now holds 1,215,051 shares of MBX.

This purchase represents a 2.00% increase in Hawryluk P. Kent's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, March 13, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026 at 8:02 AM ET, 3 days after the trade was made.

Mbx Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.